|
MUS81 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.230600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.090800E-01 |
| Normal-vs-Stage2 |
1.572380E-01 |
| Normal-vs-Stage3 |
2.727400E-01 |
| Normal-vs-Stage4 |
5.237400E-01 |
| Stage1-vs-Stage2 |
6.744300E-03 |
| Stage1-vs-Stage3 |
5.278900E-03 |
| Stage1-vs-Stage4 |
8.167600E-01 |
| Stage2-vs-Stage3 |
4.984200E-01 |
| Stage2-vs-Stage4 |
5.911500E-02 |
| Stage3-vs-Stage4 |
7.782400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.049400E-01 |
| Normal-vs-AfricanAmerican |
4.149000E-01 |
| Normal-vs-Asian |
1.936190E-02 |
| Caucasian-vs-AfricanAmerican |
5.583800E-01 |
| Caucasian-vs-Asian |
1.758250E-02 |
| AfricanAmerican-vs-Asian |
2.718800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.584400E-01 |
| Normal-vs-Female |
8.190200E-01 |
| Male-vs-Female |
9.531000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.221200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.361200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.452400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.673400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.577700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.359200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.507820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.544630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.363400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.448200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.715800E-03 |
| Classical-VS-Follicular |
3.9703000000002E-05 |
| Classical-VS-Other |
7.118800E-01 |
| Classical-VS-Normal |
1.288780E-01 |
| Tall-VS-Follicular |
2.711200E-01 |
| Tall-VS-Other |
5.599200E-01 |
| Tall-VS-Normal |
3.793600E-01 |
| Follicular-VS-Other |
3.054200E-01 |
| Follicular-VS-Normal |
4.416200E-02 |
| Other-VS-Normal |
8.079600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.320400E-01 |
| Normal-vs-N1 |
1.384390E-01 |
| N0-vs-N1 |
5.275900E-02 |
|
|
